569 related articles for article (PubMed ID: 36657303)
1. Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology.
Zhang G; Hou J; Mei C; Wang X; Wang Y; Wang K
Biomed Pharmacother; 2023 Mar; 159():114260. PubMed ID: 36657303
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer.
Huang X; Guo H; Wang L; Yang L; Shao Z; Zhang W
Mol Ther Nucleic Acids; 2022 Mar; 27():947-955. PubMed ID: 35211355
[TBL] [Abstract][Full Text] [Related]
3. N6-Methyladenosine Modification Opens a New Chapter in Circular RNA Biology.
Wu J; Guo X; Wen Y; Huang S; Yuan X; Tang L; Sun H
Front Cell Dev Biol; 2021; 9():709299. PubMed ID: 34368159
[TBL] [Abstract][Full Text] [Related]
4. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.
Lin H; Wang Y; Wang P; Long F; Wang T
Mol Cancer; 2022 Jul; 21(1):148. PubMed ID: 35843942
[TBL] [Abstract][Full Text] [Related]
5. Novel insights into the interaction between N6-methyladenosine modification and circular RNA.
Xu T; He B; Sun H; Xiong M; Nie J; Wang S; Pan Y
Mol Ther Nucleic Acids; 2022 Mar; 27():824-837. PubMed ID: 35141044
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between N6-methyladenosine modification and circular RNAs: current understanding and future directions.
Wang X; Ma R; Zhang X; Cui L; Ding Y; Shi W; Guo C; Shi Y
Mol Cancer; 2021 Sep; 20(1):121. PubMed ID: 34560891
[TBL] [Abstract][Full Text] [Related]
7. The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma.
Qin S; Mao Y; Chen X; Xiao J; Qin Y; Zhao L
Int J Biol Sci; 2021; 17(12):3059-3079. PubMed ID: 34421350
[TBL] [Abstract][Full Text] [Related]
8. Circular RNAs, Noncoding RNAs, and N6-methyladenosine Involved in the Development of MAFLD.
Nakashima M; Suga N; Ikeda Y; Yoshikawa S; Matsuda S
Noncoding RNA; 2024 Feb; 10(1):. PubMed ID: 38392966
[TBL] [Abstract][Full Text] [Related]
9. The relationship between the network of non-coding RNAs-molecular targets and N6-methyladenosine modification in tumors of urinary system.
Li R; Zhu C; Wang Y; Wang X; Wang Y; Wang J; Wang K
Cell Death Dis; 2024 Apr; 15(4):275. PubMed ID: 38632251
[TBL] [Abstract][Full Text] [Related]
10. RNA m6A modification in liver biology and its implication in hepatic diseases and carcinogenesis.
Ma W; Wu T
Am J Physiol Cell Physiol; 2022 Oct; 323(4):C1190-C1205. PubMed ID: 36036444
[TBL] [Abstract][Full Text] [Related]
11. Advances in detecting N6-methyladenosine modification in circRNAs.
Ma L; He LN; Kang S; Gu B; Gao S; Zuo Z
Methods; 2022 Sep; 205():234-246. PubMed ID: 35878749
[TBL] [Abstract][Full Text] [Related]
12. The role of N
Zhang L; Hou C; Chen C; Guo Y; Yuan W; Yin D; Liu J; Sun Z
Mol Cancer; 2020 Jun; 19(1):105. PubMed ID: 32522202
[TBL] [Abstract][Full Text] [Related]
13. N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs - an updated review.
Zhang Y; Xu Y; Bao Y; Luo Y; Qiu G; He M; Lu J; Xu J; Chen B; Wang Y
Epigenetics; 2023 Dec; 18(1):2260213. PubMed ID: 37766615
[TBL] [Abstract][Full Text] [Related]
14. N6-methyladenosine-modified circTEAD1 stabilizes Yap1 mRNA to promote chordoma tumorigenesis.
Li H; Tang Y; Ruan X; Zhang J; Liu H; Yu S; Chen H; Yang H; Zhang K; Chen K
Clin Transl Med; 2024 Apr; 14(4):e1658. PubMed ID: 38659080
[TBL] [Abstract][Full Text] [Related]
15. The functions of N6-methyladenosine modification in lncRNAs.
He RZ; Jiang J; Luo DX
Genes Dis; 2020 Dec; 7(4):598-605. PubMed ID: 33335959
[TBL] [Abstract][Full Text] [Related]
16. Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers.
Dai XY; Shi L; Li Z; Yang HY; Wei JF; Ding Q
Front Oncol; 2021; 11():635329. PubMed ID: 33928028
[TBL] [Abstract][Full Text] [Related]
17. Identification and Characterization of N6-Methyladenosine CircRNAs and Methyltransferases in the Lens Epithelium Cells From Age-Related Cataract.
Li P; Yu H; Zhang G; Kang L; Qin B; Cao Y; Luo J; Chen X; Wang Y; Qin M; Wu J; Huang Y; Zou X; Guan H; Wang Y
Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):13. PubMed ID: 32761139
[TBL] [Abstract][Full Text] [Related]
18. The Role of
Tang M; Lv Y
Int J Biol Sci; 2021; 17(9):2262-2277. PubMed ID: 34239354
[TBL] [Abstract][Full Text] [Related]
19. Overview of m
Zhang L; Wang X; Zhao W; Liu J
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6769-6784. PubMed ID: 36807759
[TBL] [Abstract][Full Text] [Related]
20. Function of N6-Methyladenosine Modification in Tumors.
Zhang N; Zuo Y; Peng Y; Zuo L
J Oncol; 2021; 2021():6461552. PubMed ID: 34858499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
